PMA P150025S004
- Device
- PD-L1 IHC NIVOLUMAB PHARMDX
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P150025
- Supplement
- S004
- Product code
- PLS
- Decision date
- 2017-03-24
- Classification
- Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1
- Generic name
- Immunohistochemistry assay, antibody, programmed death-ligand 1
- Approval order statement
- Approval for an update to DakoLink software version 4.2.
Current openFDA PMA Record#
- Device
- PD-L1 IHC NIVOLUMAB PHARMDX
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P150025
- Supplement
- S004
- Product code
- PLS
- Generic name
- Immunohistochemistry assay, antibody, programmed death-ligand 1
- Decision date
- 2017-03-24
- Decision code
- APPR
- Date received
- 2016-12-27
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Approval order statement
- Approval for an update to DakoLink software version 4.2.